Recent Updates
Recently added Catalysts
RLAY Positive Sentiment

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

Thursday, October 30, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics, a clinical-stage precision medicine company, is set to announce its financial results for the third quarter of 2025 and corporate highlights on November 6, 2025. This report will be made public after the closing of the U.S. financial markets. The company’s efforts to revolutionize drug discovery through advanced technologies will be an anticipated focus of the announcement.
Price reaction · baseline $7.31 (2025-10-29 close) · hit after-hours · 1 other RLAY headline(s) in the window, move may be shared
day 0 close
+0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Company is on track to report third quarter financial results.
  • Highlighting corporate developments reflects ongoing progress.
  • Focus on combining computational and experimental technologies.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025 financial results and corporate highlights after the U.S. financial markets close on Thursday, November 6, 2025.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics report Q3 2025 results?

Relay Therapeutics will report Q3 2025 results on November 6, 2025.

What is Relay Therapeutics focused on?

Relay Therapeutics specializes in precision medicine and drug discovery.

What technologies does Relay Therapeutics use?

The company combines computational and experimental technologies.

What is the Nasdaq symbol for Relay Therapeutics?

Relay Therapeutics is traded under the symbol RLAY on Nasdaq.

Where is Relay Therapeutics based?

Relay Therapeutics is headquartered in Cambridge, Massachusetts.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics financial results Q3 2025 corporate highlights
Last updated: Oct 30, 2025

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →